✅ Product Benefits

1. Dual‑mechanism glycaemic control — Empagliflozin increases urinary glucose excretion; Linagliptin enhances incretin hormones to boost insulin and reduce glucagon in a glucose-dependent manner Flexible dosing —

   Start with 10 mg/5 mg once daily, and escalate to 25 mg/5 mg if needed to improve glycaemic response 

2. Convenient once-daily administration — Simple regimen suited for improved adherence; may be taken with or without food .

3. Renal function-based use — Initiate only if eGFR ≥ 45 mL/min/1.73 m²; discontinue if eGFR falls below 45 due to safety considerations 

4. Cardiovascular benefit potential — Empagliflozin component may reduce risk of cardiovascular death in patients with established cardiovascular disease (consistent with SGLT2 inhibitor outcomes) .

5. Low hypoglycemia risk — When used alone, poses minimal risk of low blood sugar; risk increases only in combination with insulin or insulin secretagogues 

6. Well‑tolerated safety profile — Common side effects include urinary tract infections, nasopharyngitis, upper respiratory infections, increased LDL cholesterol, and hematocrit; ketoacidosis and genital infections are rare but serious risks .

7. Affordable and widely available in Bangladesh — Priced at approximately ৳40 per tablet (৳400 per strip of 10) and stocked across most pharmacies nationwide